drugset / Trial / NCT00834249

Venlafaxine 25 mg Tablets Under Non-Fasting Conditions

NCT00834249

Phase 1 Completed 18 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of venlafaxine 25 mg tablets (test) versus Effexor® (reference) administered as 1 x 25 mg tablet under fed conditions.

Timeline

Start
2002-12
Primary completion
2002-12
Completion
2002-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Venlafaxine Small molecule 25 mg

Indications

No indication recorded.